CM 611 (Invokamet 150 mg / 1000 mg)
Generic Name: canagliflozin/metformin
Pill with imprint CM 611 is Purple, Capsule-shape and has been identified as Invokamet 150 mg / 1000 mg. It is supplied by Janssen Pharmaceuticals, Inc..
Invokamet is used in the treatment of diabetes, type 2; cardiovascular risk reduction and belongs to the drug class antidiabetic combinations. Risk cannot be ruled out during pregnancy. Invokamet 150 mg / 1000 mg is not a controlled substance under the Controlled Substances Act (CSA).
Images for CM 611
Invokamet
- Generic Name
- canagliflozin/metformin
- Imprint
- CM 611
- Strength
- 150 mg / 1000 mg
- Color
- Purple
- Shape
- Capsule-shape
- Availability
- Prescription only
- Drug Class
- Antidiabetic combinations
- Pregnancy Category
- C - Risk cannot be ruled out
- CSA Schedule
- Not a controlled drug
- Labeler / Supplier
- Janssen Pharmaceuticals, Inc.
- National Drug Code (NDC)
- 50458-0543
More about Invokamet (canagliflozin / metformin)
- Side Effects
- During Pregnancy
- Dosage Information
- Drug Images
- Drug Interactions
- Pricing & Coupons
- En Español
- 2 Reviews
- Drug class: antidiabetic combinations
- FDA Alerts (7)
- FDA Approval History
Consumer resources
- Other brands
- Invokamet XR
Professional resources
Related treatment guides
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.